PeptideDB

Galloylpaeoniflorin (6'-O-Galloyl paeoniflorin) 122965-41-7

Galloylpaeoniflorin (6'-O-Galloyl paeoniflorin) 122965-41-7

CAS No.: 122965-41-7

Galloylpaeoniflorin is an inhibitor (blocker/antagonist) of NF-κB. And Galloylpaeoniflorin is an inhibitor (blocker/ant
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Galloylpaeoniflorin is an inhibitor (blocker/antagonist) of NF-κB. And Galloylpaeoniflorin is an inhibitor (blocker/antagonist) of DNA cleavage.

Physicochemical Properties


Molecular Formula C30H32O15
Molecular Weight 632.57
Exact Mass 632.174
CAS # 122965-41-7
PubChem CID 101604718
Appearance White to off-white solid powder
Density 1.7±0.1 g/cm3
Boiling Point 887.7±65.0 °C at 760 mmHg
Flash Point 290.8±27.8 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.735
LogP 4.89
Hydrogen Bond Donor Count 7
Hydrogen Bond Acceptor Count 15
Rotatable Bond Count 10
Heavy Atom Count 45
Complexity 1170
Defined Atom Stereocenter Count 11
SMILES

C[C@]12C[C@@]3([C@@H]4C[C@]1([C@@]4([C@H](O2)O3)COC(=O)C5=CC=CC=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)COC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)O)O

InChi Key KLFIUQCKSSAFFU-QHOIGUMUSA-N
InChi Code

InChI=1S/C30H32O15/c1-27-11-29(39)18-9-30(27,28(18,26(44-27)45-29)12-41-23(37)13-5-3-2-4-6-13)43-25-22(36)21(35)20(34)17(42-25)10-40-24(38)14-7-15(31)19(33)16(32)8-14/h2-8,17-18,20-22,25-26,31-36,39H,9-12H2,1H3/t17-,18-,20-,21+,22-,25+,26-,27+,28+,29-,30+/m1/s1
Chemical Name

[(2R,3S,4S,5R,6S)-6-[[(1R,2S,3R,5R,6R,8S)-2-(benzoyloxymethyl)-6-hydroxy-8-methyl-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Lu Y, Liu W, Zhang M, Deng Y, Jiang M, Bai G. The Screening Research of NF-κB Inhibitors from Moutan Cortex Based on Bioactivity-Integrated UPLC-Q/TOF-MS. Evid Based Complement Alternat Med. 2019;2019:6150357. Published 2019 Mar 3.

[2]. OKUBO T., NAGAI F., USHIYAMA K., SETO T., SATOH K., KANO I.THE INHIBITORY EFFECTS OF MOUTAN CORTEX AND PAEONIAE ON RADIX ON OXIDATIVE DNA DAMAGE BY T-BUTYLHYDROQUINONE, PHENOLIC ANTIOXIDANT.Mutation Research, 1997.

Additional Infomation [(2R,3S,4S,5R,6S)-6-[[(1R,2S,3R,5R,6R,8S)-2-(benzoyloxymethyl)-6-hydroxy-8-methyl-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate has been reported in Paeonia tenuifolia and Phellodendron amurense with data available.

Solubility Data


Solubility (In Vitro) DMSO :~100 mg/mL (~158.09 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (3.95 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (3.95 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (3.95 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.5809 mL 7.9043 mL 15.8085 mL
5 mM 0.3162 mL 1.5809 mL 3.1617 mL
10 mM 0.1581 mL 0.7904 mL 1.5809 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.